Healthcare of Ontario Pension Plan Trust Fund Purchases 1,000,000 Shares of RxSight, Inc. $RXST

Healthcare of Ontario Pension Plan Trust Fund raised its position in RxSight, Inc. (NASDAQ:RXST) by 761.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,131,400 shares of the company’s stock after buying an additional 1,000,000 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in RxSight were worth $6,969,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of RXST. Walleye Capital LLC boosted its position in shares of RxSight by 258.6% in the first quarter. Walleye Capital LLC now owns 314,616 shares of the company’s stock valued at $1,938,000 after acquiring an additional 226,871 shares during the period. Summit Securities Group LLC acquired a new stake in RxSight in the 1st quarter worth about $30,000. Rockefeller Capital Management L.P. raised its stake in RxSight by 27.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 23,848 shares of the company’s stock worth $248,000 after purchasing an additional 5,203 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in RxSight by 19.7% in the 4th quarter. Corient Private Wealth LLC now owns 36,095 shares of the company’s stock valued at $376,000 after purchasing an additional 5,933 shares during the period. Finally, Caitong International Asset Management Co. Ltd grew its position in shares of RxSight by 511.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,249 shares of the company’s stock worth $44,000 after purchasing an additional 3,554 shares in the last quarter. Institutional investors and hedge funds own 78.78% of the company’s stock.

RxSight Trading Up 1.3%

Shares of RxSight stock opened at $6.13 on Thursday. The company has a 50 day moving average of $5.27 and a 200-day moving average of $6.80. RxSight, Inc. has a 1-year low of $4.48 and a 1-year high of $13.22. The company has a market cap of $253.78 million, a PE ratio of -5.42 and a beta of 1.15.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on RXST. Bank of America lowered their target price on shares of RxSight from $8.00 to $6.50 and set an “underperform” rating on the stock in a report on Tuesday, July 7th. Wells Fargo & Company reduced their price target on RxSight from $11.00 to $9.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 7th. UBS Group restated a “neutral” rating and set a $5.50 price objective (down from $9.00) on shares of RxSight in a research note on Tuesday. Wall Street Zen raised RxSight from a “strong sell” rating to a “sell” rating in a report on Sunday, July 12th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $11.00 price objective on shares of RxSight in a report on Tuesday, July 7th. Two equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $8.50.

About RxSight

RxSight, Inc is a medical technology company focused on the development and commercialization of advanced intraocular lens (IOL) systems for patients undergoing cataract surgery and lens replacement procedures. The company’s flagship product, the Light Adjustable Lens (LAL), is designed to provide customized vision correction by allowing non‐invasive post‐operative adjustments. Using ultraviolet light, surgeons can fine‐tune the lens power after implantation to achieve optimal visual outcomes, reducing reliance on glasses or contact lenses and enhancing patient satisfaction.

Founded in 2011 and headquartered in Aliso Viejo, California, RxSight has pursued regulatory clearances and market access across multiple regions.